Asthma improvement in patients treated with dupilumab for severe atopic dermatitis

INTRODUCTION: Atopic dermatitis (AD) is considered a systemic type 2 immune driven disease, and it is associated to many atopic comorbidities including asthma. The aim of our study was to prospectively evaluate the respiratory outcomes in patients with persistent allergic asthma treated with dupilum...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubini, Marco, Benzecry, Valentina, Rivolta, Federica, Sangalli, Andrea, Marzano, Angelo Valerio, Pravettoni, Valerio, Tavecchio, Simona, Ferrucci, Silvia Mariel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Allergy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518613/
https://www.ncbi.nlm.nih.gov/pubmed/37753208
http://dx.doi.org/10.3389/falgy.2023.1223657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518613/
https://www.ncbi.nlm.nih.gov/pubmed/37753208
http://dx.doi.org/10.3389/falgy.2023.1223657

Ejemplares similares